Upload
hyper-wellbeing
View
163
Download
0
Embed Size (px)
Citation preview
Enabling Access to Continuous Metabolic Data for Personalized Nutrition and Wellbeing
Ashwin Pushpala
*Source: Cell Press. "'Healthy' foods differ by individual." ScienceDaily. ScienceDaily, 19 November 2015.
Research* shows high variability in response to identical meals — suggesting universal dietary recommendations may have limited utility.
Participant 1 Participant 2
Banana
Variable sugar response to similar foods
Cookie
Novel silicon sensor technology
Our patented chemical sensing platform and signal-processing
algorithms enable understanding of metabolism and nutrition at the
individual level.
New behavior and habits
Our products can help people establish healthy patterns by giving them
knowledge about what their bodies need and a strategy for how to get
there.
Help millions of people understand what is happening inside their bodies so they can make thoughtful choices about the way they eat, move, and live.
Personalized metabolic insights in real-time
Sano is the world’s first company to give people continuous and
personalized insights into their bodies’ chemistry — bringing personalized
nutrition to all.
We want to fundamentally change the way that people think about diet, nutrition, and metabolism.
Rather than thinking of these as roadblocks, we want people to use their unique metabolic profiles as a strategy for
success.
Rather than thinking of these as roadblocks, we want people to use their unique metabolic profiles as a strategy for success.
*Source: 2015 Sano Consumer Survey (n = 1500)
2 of 3people* say seeing sugar levels
continuously would help them feel better throughout the day by knowing how food
affects their bodies
Sugar is the main culprit for metabolic challenges with nutrition, and it is the first application for our technology.
86%of dieters are looking to cut down
on foods high in sugar
115 millionpeople in the US affected by elevated
blood sugar (almost 50% of adults)
CGM technology is only available to T1 and insulin-intensive T2
patients — the rest of the population managing this chronic
condition can only do so with finger-prick measurements.
DISEASE MANAGEMENT
fitness focused
5mm
We’re starting with the preventive segment of the market unserved by products on the market today.
healthy
40mm
overweight
110mm
pre-diabetic
86mm
T2 diabetic
29mm
insulin-intensive T2 diabetic
1.5mm
T1 diabetic
2mm
PREVENTIVE
SensePatch continuously senses metabolic data
1 InsightData is visualized in the UI, along with contextualized suggestions for diet, nutrition, fitness, etc.
4
Our system continuously collects and analyzes metabolic data to provide actionable, timely insights.
ProcessSmartphone uploads raw sensor data to the cloud, where it is processed and analyzed
3
4
TransmitData is transmitted through BLE to a paired smartphone
2
50
75
100
125
150
175
200
8:09 AM 8:38 AM 9:07 AM 9:36 AM 10:04 AM 10:33 AM 11:02 AM 11:31 AM 12:00 PM 12:28 PM 12:57 PM
sano dexcom finger stick
Our proprietary, transdermal chemical sensing technology platform enables diagnostic-level accuracy in a painless manner.
We’ve made the overarching goal of the product to be quite simple — stabilize sugar concentrations. And we’ve designed a metric (minutes in target zone) that enables people to track this goal in continuously.
Our software is based on continuous feedback loops that happen at 3 different time scales — all focused on helping people maintain stability.
ReflectionReview personalized insights related to what happened during the day to plan future activity and food choices for the next day.
MEDIUM TERM / TODAY
Real-time feedbackSee the impact of recent actions (e.g. heavy lunch) and correct or prevent undesirable situations.
SHORT TERM / NOW
Pattern discoveryUnderstand how habits and behaviors affect personal health and establish new healthy patterns over time.
LONG TERM / HISTORY
Consumer (Glucose)‣ Target audience:
- weight loss- fitness enthusiasts
‣ Features:- Real-time, continuous glucose in normal
zone (70-150 mg/dL)- Time in “stable” glucose region- Information about future glucose trends- Diet programs and/or experiments- Lifestyle & nutrition advice
‣ Regulatory: Enforcement discretion
Our product roadmap starts with a consumer product launch in 2017 aimed at general health/wellness and diet. We will then seek approval for a diabetes-focused product and release other diagnostics.
20182017 2019
Clinical (Glucose)‣ Target audience:
- T1 diabetics- T2 diabetics
‣ Features:- Real-time, continuous glucose at
all concentration ranges- Treatment advice for T2 diabetics
‣ Regulatory: Class III PMA
Other analytes‣ Electrolytes (sodium, potassium, calcium, etc.)‣ Lactic acid‣ Cholesterol‣ Ethanol‣ Cortisol‣ etc.
Team with deep experience in engineering, data science, hardware, manufacturing, supply chain, consumer devices and biochemistry.